S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI spot101.91▲ 1.04%
Home › CVV › Research report
← CVV page
XStocksXray
Market X-Ray report · 21 October 2026

CanAlaska Uranium Ltd (CVV)

TSX Venture Exchange · Canada · prices in CAD · close of 21 Oct 2026

Key indicators

Last closeCAD 0.270
52-week range0.270 – 1.020
Return, 1 month / 3 months−22.9% / −25.0%
Return, 1 year / 3 years−69.3% / −42.9%
TrendBelow its 200-day average
RSI (14)36
Volatility (1 year)89.2%
Worst drawdown (1 year)-72.7%
Average daily value traded0.18M CAD
Dividend yield–

Market X-Ray price-based

32/ 100 · High confidence · ahead of 22% of stocks on this exchange
Trend8
Momentum13
Stability (higher is calmer)40
Liquidity91
Income–

Five-year price chart navy: price · brown: 200-day average

0.210.460.710.961.212021-102023-012024-042025-072026-10

About the company

CanAlaska Uranium Ltd is a mineral exploration company based in Vancouver, Canada, that focuses on uranium. It works mainly in the Athabasca Basin region of northern Saskatchewan, an area associated with high-grade uranium deposits. The company acquires and explores land packages, often through joint ventures with other mining firms, and its activities centre on geological surveying, drilling and resource definition rather than mining or processing uranium itself.

The shares are listed on the TSX Venture Exchange in Canada under the code CVV, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

CanAlaska Uranium Ltd (CVV) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.270 on 21 October 2026.

Its price-based Market X-Ray is 32 out of 100 (a weak price profile), ranking 1,167 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 69.3% and over the last three months it fell 25.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
CanAlaska Uranium Ltd (CVV)

The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange

Lens and metricValueScoreReading
Trend8 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-52.8%
From 52-week high-72.7%
Momentum13 · WeakLagging most stocks on this exchange.
3-month return-25.0%
6-month return-61.4%
12-month return, skipping the last month-60.2%
Stability (higher is calmer)40 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)89.2%
Worst drawdown, 1 year (smaller is calmer)-72.7%
Liquidity91 · StrongTrades actively.
Average daily value traded0.18M CAD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.6%
1 month−22.9%
3 months−25.0%
6 months−61.4%
1 year−69.3%
3 years−42.9%
5 years–

Signals

50-day / 200-day average0.342 / 0.571
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.022

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 0 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026